Catalyst Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 21.46
| CPRX Stock | USD 22.11 0.37 1.70% |
Closest to current price Catalyst long CALL Option Payoff at Expiration
Catalyst |
Catalyst Pharmaceuticals Target Price Odds to finish over 21.46
The tendency of Catalyst Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 21.46 in 90 days |
| 22.11 | 90 days | 21.46 | about 38.65 |
Based on a normal probability distribution, the odds of Catalyst Pharmaceuticals to stay above $ 21.46 in 90 days from now is about 38.65 (This Catalyst Pharmaceuticals probability density function shows the probability of Catalyst Stock to fall within a particular range of prices over 90 days) . Probability of Catalyst Pharmaceuticals price to stay between $ 21.46 and its current price of $22.11 at the end of the 90-day period is about 20.6 .
Given the investment horizon of 90 days Catalyst Pharmaceuticals has a beta of 0.99 suggesting Catalyst Pharmaceuticals market returns are sensitive to returns on the market. As the market goes up or down, Catalyst Pharmaceuticals is expected to follow. Additionally Catalyst Pharmaceuticals has an alpha of 0.0748, implying that it can generate a 0.0748 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Catalyst Pharmaceuticals Price Density |
| Price |
Predictive Modules for Catalyst Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Catalyst Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Catalyst Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Catalyst Pharmaceuticals is not an exception. The market had few large corrections towards the Catalyst Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Catalyst Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Catalyst Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | 0.99 | |
σ | Overall volatility | 1.04 | |
Ir | Information ratio | 0.04 |
Catalyst Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Catalyst Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Catalyst Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 83.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Janus Henderson Group PLC Has 7.16 Million Position in Catalyst Pharmaceuticals, Inc. - MarketBeat |
Catalyst Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Catalyst Stock often depends not only on the future outlook of the current and potential Catalyst Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Catalyst Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 113.8 M | |
| Cash And Short Term Investments | 137.6 M |
Catalyst Pharmaceuticals Technical Analysis
Catalyst Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Catalyst Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Catalyst Pharmaceuticals. In general, you should focus on analyzing Catalyst Stock price patterns and their correlations with different microeconomic environments and drivers.
Catalyst Pharmaceuticals Predictive Forecast Models
Catalyst Pharmaceuticals' time-series forecasting models is one of many Catalyst Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Catalyst Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Catalyst Pharmaceuticals
Checking the ongoing alerts about Catalyst Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Catalyst Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Over 83.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Janus Henderson Group PLC Has 7.16 Million Position in Catalyst Pharmaceuticals, Inc. - MarketBeat |
Additional Tools for Catalyst Stock Analysis
When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.